Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prioritizing Discovery and Advancements in Arrhythmia Therapies: NIH/NHLBI Workshop.

JACC. Clinical electrophysiology·2026
Same author

Leveraging nanoparticle protein corona to advance plasma proteome profiling.

Nature communications·2026
Same author

Beta-Adrenergic Stimulation and <i>MYH7</i> G256E Mutant Gene Dosage Drive Hypertrophic Cardiomyopathy Phenotype Penetrance.

bioRxiv : the preprint server for biology·2026
Same author

Modeling early human heart development using an iPSC-based 3D bioprinted model of embryonic heart tube.

Nature communications·2026
Same author

A Dynamic 3D Human Liver Sinusoid Model for Mechanistic Interrogation of Fontan-Associated Liver Disease.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Computational Modeling Meets 3D Bioprinting: Emerging Synergies in Cardiovascular Disease Modeling.

Advanced healthcare materials·2026

Related Experiment Video

Updated: Apr 19, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

11.0K

Patching up broken hearts: cardiac cell therapy gets a bioengineered boost.

Vahid Serpooshan1, Sean M Wu2

  • 1Stanford Cardiovascular Institute, Stanford, CA 94305, USA.

Cell Stem Cell
|December 7, 2014
PubMed
Summary
This summary is machine-generated.

Cardiac cell therapy shows limited success due to poor cell survival. A new fibrin patch loaded with growth factors significantly improved cardiovascular cell survival in a porcine model, enhancing cell transplantation outcomes.

More Related Videos

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair
05:05

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

6.1K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.5K

Related Experiment Videos

Last Updated: Apr 19, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

11.0K
Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair
05:05

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

6.1K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.5K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Biomaterials Science

Background:

  • Cardiac cell therapy faces challenges with low engraftment and survival rates of transplanted cells.
  • Improving cell survival is critical for the efficacy of cardiac regenerative therapies.

Purpose of the Study:

  • To investigate the efficacy of a novel growth-factor-loaded fibrin patch in enhancing cardiovascular cell survival post-transplantation.
  • To assess the impact of this biomaterial on cell survival in a relevant preclinical model.

Main Methods:

  • Development of a fibrin patch incorporating growth factors.
  • Cell transplantation into a porcine model of ischemia-reperfusion injury.
  • Evaluation of cardiovascular cell survival and engraftment.

Main Results:

  • The growth-factor-loaded fibrin patch demonstrated a significant improvement in cardiovascular cell survival.
  • Enhanced cell survival was observed following transplantation in the porcine ischemia-reperfusion model.

Conclusions:

  • Growth-factor-loaded fibrin patches represent a promising strategy to overcome cell survival limitations in cardiac cell therapy.
  • This approach holds potential for improving the therapeutic outcomes of regenerative strategies for heart disease.